Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Grifols, S.A.
  6. News
  7. Sector news
    GRF   ES0171996087

GRIFOLS, S.A.

(GRF)
  Report
Delayed Bolsas y Mercados Espanoles  -  11:38 2022-10-07 am EDT
8.518 EUR   -2.23%
10/06European ADRs Fall in Thursday Trading
MT
10/05European ADRs Move Sharply Lower in Wednesday Trading
MT
10/03Grifols appoints executive chairman as seeks to speed recovery
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Biopharmaceuticals
11:25aBiogen Reportedly Considering Ex-Johnson & Johnson Research & Development Head as Next ..
MT
11:18aArgus Research Upgrades Biogen to Buy from Hold
MT
06:35aBarclays Adjusts Price Target on Biogen to $275 From $200, Keeps Equalweight Rating
MT
01:41aWuxi Biologics Repurchases $22.5 Million Shares
MT
10/06UBS Adjusts Biogen Price Target to $309 From $238, Maintains Buy Rating
MT
10/06RBC Cuts Price Target on Biogen to $310 From $321, Maintains Outperform Rating
MT
10/05CSL Limited Announces Positive Preclinical Data for Self-Amplifying Messenger RNA (sa-m..
CI
10/03Biogen, Denali Start Phase 3 Trial of BIIB122 to Treat Parkinson's Disease Linked to LR..
MT
10/03U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent
RE
10/03U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent
RE
10/03Biogen Inc. and Denali Therapeutics Announce Initiation of the Phase 3 Lighthouse Study..
CI
10/03Alexion Pharmaceuticals, Inc. entered into a defini..
CI
09/30WuXi Biologics Inc. commences an Equity Buyback Plan for 425,926,547 shares, representi..
CI
09/30JPMorgan Adjusts Biogen's Price Target to $275 from $221, Maintains Neutral Rating
MT
09/30Biogen Says EMA Accepts Marketing Authorization Application for Biosimilar Candidate fo..
MT
09/30Biogen Inc. Announces European Medicines Agency Filing Acceptance of BIIB800, A Biosimi..
CI
09/30Biogen: EMA Accepts Application for RoActemra Biosimilar
DJ
09/29Oppenheimer Adjusts Biogen Price Target to $300 From $230, Maintains Outperform Rating
MT
09/29Eisai Shares Skyrocket 14% on Favorable Results of Alzheimer's Drug
MT
09/29Trending : Eisai Shares Rise After Alzheimer's Drug Shows Promise
DJ
09/28Wuxi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility in Worc..
CI
09/28US Stocks Climb Wednesday, Yields Slump After Bank of England Move
MT
09/28US Stocks Climb Wednesday Following Bank of England Move
MT
09/28Biogen's Latest Data for Alzheimer's Drug Raises Likelihood for Approval, May Lead to '..
MT
09/28Wall Street ends sharply higher as Treasury yields dip
RE
09/28Sector Update: Health Care Stocks Finishing Wednesday Trade Near Intra-Day..
MT
09/28Wall Street ends sharply higher as Treasury yields dip
RE
09/28Wall Street bounces back as Treasury yields dip
RE
09/28Top Midday Gainers
MT
09/28Sector Update: Health Care Stocks Surging Wednesday
MT
09/28Drug Companies Pursuing Alzheimer Treatments See Shares Rise Wednesday
DJ
09/28Equities Rebound Midday After Bank of England Moves to Support UK's Bond Market
MT
09/28Sector Update: Health Care
MT
09/28Wall Street jumps over 1% in choppy trading as yields dip
RE
09/28Biogen Jumps After Alzheimer's Disease Treatment Meets Primary Endpoint in Phase 3 Tria..
MT
09/28Wall Street Set to Open Mixed Ahead of Pending Home Sales Report, Powell's Remarks at B..
MT
09/28Sector Update: Health Care Stocks Rally Premarket Wednesday
MT
09/28Sector Update: Health Care
MT
09/28US Futures Lower Ahead of Pending Home Sales Report, Powell's Remarks at Banking Confer..
MT
09/28Wells Fargo Adjusts Biogen's Price Target to $350 From $265, Reiterates Overweight Rati..
MT
09/28RBC Lifts Price Target on Prothena to $52 From $45, Says Biogen/Eisai's Lecanemab Data ..
MT
09/28Biogen Receives Price Target Boost From RBC to $321 From $251 After 'Strong,' 'Transfor..
MT
09/28Top Premarket Gainers
MT
09/28Wedbush Raises Biogen's Price Target to $217 From $183 on Likely Lecanemab Approval, Ma..
MT
09/28Baird Upgrades Biogen to Outperform From Neutral, Adjusts Price Target to $340 From $22..
MT
09/28Biogen, Eisai Say Alzheimer's Treatment Met Primary, Secondary Endpoints in Phase 3 Tri..
MT
09/28Analyst recommendations: Accenture, Biogen, Fedex, Netflix, Phil..
MS
09/28Piper Sandler Adjusts Biogen's Price Target to $280 From $200, Maintains Neutral Rating
MT
09/28BMO Capital Lifts Biogen to Outperform From Market Perform, Price Target to $360 From $..
MT
09/28Mizuho Securities Raises Biogen to Buy From Neutral, Price Target to $270 From $207 on ..
MT
09/28Biogen, Eisai stocks soar on Alzheimer's success, lifting rival shares
RE
09/28Japan Index Adds Losses on Economic Uncertainty; Eisai Shares Skyrocket 17% on Favorabl..
MT
09/27Eisai Shares Indicated Sharply Higher After Trial of Experimental Drug Slows Alzheimer'..
DJ
09/27Alzheimer's drug study yields positive results, say makers Eisai and Biogen
RE
09/27Eisai says Alzheimer's drug succeeds in slowing cognitive decline
RE
09/27Eisai Co. and Biogen Announce Positive Topline Results from Eisai's Large Global Phase ..
CI
09/26DOJ Says Biogen in Settlement; Agreement-in-Principle Previously Disclosed
DJ
09/25Wuxi Biologics Shares Jump After Buyback Plans
DJ
09/25Wuxi Biologics to Conduct up to $300 Million Share Buyback; Stock Jumps 5%
MT
09/22Australia shares hit over two-month low on Fed's stance; banks, tech stocks weigh
RE
09/22Truist Securities Adjusts Biogen's Price Target to $265 from $270, Maintains Buy Rating
MT
09/20Boston Properties Acquires Laboratory, Life Sciences Property in Massachusetts From Bio..
MT
09/20Boston Properties, Inc. acquired 125 Broadway, A six story 271,000 Square Foot Laborato..
CI
09/19WuXi Biologics Inc. Receives Regulatory Approvals for Drug Substance and Drug Product F..
CI
09/16Alexion Pharmaceuticals, Inc Announces Danicopan Add-On to Ultomiris (Ravulizumab-Cwvz)..
CI
09/15New energy shares drag China stocks lower; Hong Kong gains
RE
09/15New energy shares drag China stocks lower, Fed rate-decision jitters weigh
RE
09/13CSL Inaugurates its New EUR 150 Million Research and Development Site on Grounds of Res..
CI
09/13China stocks rise after Premier Li vows to stabilise growth
RE
09/12Wuxi Biologics, Peers Slump After Biden Signs Order to Boost U.S. Biotech Industry
DJ
09/12Stifel Nicolaus Lowers Biogen's Price Target to $223 From $230, Maintains Hold Rating
MT
09/12Transcript : Biogen Inc. Presents at Morgan Stanley 20th Annual Global Health..
CI
09/08Autobahn Therapeutics, Inc. announced that it has received $32.7 million in funding fro..
CI
09/07Biogen Inc. Announces That the New England Journal of Medicine Has Published A Second M..
CI
09/05S.Korean shares end at over six-week low on Europe energy worries
RE
09/02RBC Capital Cuts Price Target on Biogen to $251 From $259, Keeps Outperform Rating
MT
08/31Wuxi Biologics Announces GMP Release of Its First North American Biomanufacturing Facil..
CI
08/23Financial, healthcare stocks drag Australian shares to near three-week low
RE
08/22UBS Adjusts Wuxi Biologics' Price Target to HK$113.12 From HK$110.67, Keeps at Buy
MT
08/18Transcript : WuXi Biologics Inc., Q2 2022 Earnings Call, Aug 18, 2022
CI
08/18Wuxi Biologics' H1 Net Profit Rises 37.6% as Revenue Tops Estimate; Shares Climb 3%
MT
08/17Wuxi Biologics 1st Half Net Profit Rises 38% on Year
DJ
08/17CSL Limited Announces Positive Top-Line Phase 3 Results for Garadacimab as Preventive T..
CI
08/17WuXi Biologics Inc. Appoints Weichang Zhou as Member of the Strategy Committee
CI
08/17WuXi Biologics Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/17Australian Shares Rise to 10-Week High as Wage Growth Continues
MT
08/17Australian shares rise after weak wage data, CSL caps gains
RE
08/16CSL FY22 Profit Declines as Pandemic Constrains Core Plasma Therapy Sales; Shares Down ..
MT
08/16Australia shares flat as miners offset CSL drag, NZ falls ahead of rates decision
RE
08/16Transcript : CSL Limited, 2022 Earnings Call, Aug 17, 2022
CI
08/16Australia biotech giant CSL reports profit dip, flags cost spiral
RE
08/16CSL annual profit drops 6% as weak plasma collections bite
RE
08/16CSL Limited Provides Earnings Guidance for the Fiscal Year 2023
CI
08/16CSL Limited Announces Final Dividend for the Period Ended June 30, 2022, Payable on 5 O..
CI
08/16CSL Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/16CSL Net Profit Falls, But Expects Growth For Coming Year
DJ
08/16Samsung Biologics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Mont..
CI
08/12WuXi Biologics Inc. Announces Change of Address of Principal Place of Business in Hong ..
CI
08/10CSL Completes Vifor Pharma Acquisition
MT
08/09UBS Starts Samsung Biologics at Buy With 1,070,000 Won Price Target
MT
Upcoming event on GRIFOLS, S.A.